204 related articles for article (PubMed ID: 1854167)
1. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.
Visser MR; Rozenberg-Arska M; Beumer H; Hoepelman IM; Verhoef J
Antimicrob Agents Chemother; 1991 May; 35(5):858-68. PubMed ID: 1854167
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of sparfloxacin compared with those of five other quinolones.
Cantón E; Pemán J; Jimenez MT; Ramón MS; Gobernado M
Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
Kim JH; Choi KH; Kim JW; Lee JH; Choi EC; Kim BK
J Antimicrob Chemother; 1998 Feb; 41(2):223-9. PubMed ID: 9533464
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
Barry AL; Fuchs PC
Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates.
Giamarellou H; Voutsinas D; Xirouchaki E
J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of DV-7751a, a new fluoroquinolone.
Tanaka M; Hoshino K; Ishida H; Sato K; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1993 Oct; 37(10):2112-8. PubMed ID: 8257132
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of lomefloxacin.
Leigh DA; Tait S; Walsh B
J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Ashby JP; Matthews RS; Wise R
J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
Wakabayashi E; Mitsuhashi S
Antimicrob Agents Chemother; 1994 Mar; 38(3):594-601. PubMed ID: 8203860
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
Ito T; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.
Akaniro JC; Stutman HR; Arguedas AG; Vargas OM
Antimicrob Agents Chemother; 1992 Feb; 36(2):255-61. PubMed ID: 1318674
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
Kim JH; Kang JA; Kim YG; Kim JW; Lee JH; Choi EC; Kim BK
Antimicrob Agents Chemother; 1997 Oct; 41(10):2209-13. PubMed ID: 9333049
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of four new fluoroquinolones.
García-Rodríguez JA; García Sánchez JE; García García MI; Fresnadillo MJ; Trujillano I; García Sánchez E
J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
Sato K; Hoshino K; Tanaka M; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
[TBL] [Abstract][Full Text] [Related]
20. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
